Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
3,492,182
-
Shares change
-
+482,134
-
Total reported value, excl. options
-
$398,275,105
-
Value change
-
+$56,018,406
-
Put/Call ratio
-
81.5%
-
Number of buys
-
56
-
Number of sells
-
-51
-
Price
-
$114.04
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2017
142 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2017.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,492,182 shares
.
Largest 10 shareholders include MORGAN STANLEY (888,872 shares), WELLS FARGO & COMPANY/MN (417,141 shares), BANK OF AMERICA CORP /DE/ (358,807 shares), UBS Group AG (345,937 shares), Navellier & Associates Inc (159,708 shares), LPL Financial LLC (103,618 shares), ROYAL BANK OF CANADA (99,089 shares), AMERIPRISE FINANCIAL INC (80,538 shares), J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD (78,537 shares), and RAYMOND JAMES & ASSOCIATES (77,095 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.